Introduction to Buprenorphine-Naloxone (BUP/NAL) Buprenorphine-Naloxone, often prescribed under brand names such as Suboxone or Zubsolv, represents a cornerstone of modern Medication-Assisted Treatment (MAT) for Opioid Use Disorder (OUD). Its introduction revolutionized addiction medicine by providing an effective, office-based treatment option, significantly expanding access compared to traditional methadone clinics. Understanding patient satisfaction with BUP/NAL is not […]
The Conceptual Framework of Medication Assisted Treatment Medication Assisted Treatment (MAT) represents a comprehensive approach to treating substance use disorders (SUDs), particularly opioid use disorder (OUD) and alcohol use disorder (AUD), integrating pharmacological interventions with counseling and behavioral therapies. The core philosophy underpinning MAT is the recognition of addiction as a chronic, relapsing brain disease, […]
Introduction: The Critical Role of Medications for Opioid Use Disorder (MOUD) The ongoing opioid crisis represents a profound public health emergency, demanding comprehensive and evidence-based interventions. Central to effective treatment for Opioid Use Disorder (OUD) are Medications for Opioid Use Disorder, commonly referred to as MOUD. These medications—primarily methadone, buprenorphine (often combined with naloxone), and […]